Date: April 5, 2023, 11:00am-1:00pm
Webinar Title: Substance Use in Organ Transplantation: Interprofessional Perspectives and Practical Strategies
Webinar Description: In this webinar, Drs. Winder and Mellinger, transplant psychiatrist and transplant hepatologist, respectively, will discuss overlapping psychiatric and medical aspects of substance use in organ transplantation candidates and recipients. Key topics include substance use epidemiology, monitoring and treatment strategies, candidate selection, personal reactions and perceptions of clinicians, transplant center policies, and future directions in clinical work and research. Objectives include: 1) increase clinician awareness and curiosity about substance-related matters in transplant, 2) provide practical perspectives and tools for immediate use in clinical work and decision-making, and 3) promote interprofessional practice.
Dr. Gerald Scott Winder is a clinical associate professor in the Departments of Psychiatry, Surgery, and Neurology at Michigan Medicine. He holds a medical degree from the University of Utah School of Medicine and a master of science degree from the University of Michigan School of Public Health. He completed a general psychiatry residency and a consultation-liaison psychiatry fellowship at the University of Michigan. As a consultation-liaison psychiatrist, Dr. Winder specializes in the psychiatric care of the medically ill. In this clinical niche, he has co-founded specialty clinics embedded in organ transplantation, neurology, and hepatology working on interprofessional teams providing integrated psychiatric and medical care to patients whose diseases cross medical disciplines.
Dr. Jessica Mellinger is an assistant professor in the Departments of Internal Medicine and Psychiatry at Michigan Medicine where she practices clinically in general and transplant hepatology with a special focus on alcohol-related liver disease. She holds a medical degree from Northwestern University’s Feinberg School of Medicine, and master’s degrees in English Literature and History of Medicine from Oxford University (United Kingdon) and a master’s in Health and Healthcare Research from the University of Michigan. Her clinical practice and research focuses on the epidemiology of alcohol-related liver disease, cost-effectiveness and access to alcohol use disorder treatments among those with ALD, and developing novel behavioral interventions to help patients with alcohol-related liver disease stop alcohol use and engage in alcohol treatment. Along with colleagues in psychiatry, in 2018 she founded the Michigan Alcohol Improvement Network’s Multidisciplinary ALD clinic, one of the first fully integrated, co-located alcohol and liver disease treatment clinics for ALD patients. She is NIH funded through the NIAAA and NIDA to study behavioral treatments in ALD.